GS-6624

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-6624, covering 2017-04-04 to 2017-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]